64 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
UTHR United Therapeutics Corporation $125.98 $5.49B N/A
Article Searches
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat http://www.zacks.com/stock/news/407647/united-therapeutics-uthr-down-despite-q1-earnings-beat?cid=CS-ZC-FT-407647 May 02, 2019 - United Therapeutics (UTHR) beats estimates on both fronts in the first quarter. However, earnings and revenues decline year over year.
United Therapeutics Corporation (UTHR) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/01/united-therapeutics-corporation-uthr-q1-2019-earni.aspx?source=iedfolrf0000001 May 01, 2019 - UTHR earnings call for the period ending March 31, 2019.
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4258555-united-therapeutics-corporation-uthr-ceo-martine-rothblatt-q1-2019-results-earnings-call?source=feed_sector_healthcare May 01, 2019 - United Therapeutics Corporation (NASDAQ:UTHR) Q1 2019 Results Earnings Conference Call May 01, 2019, 9:00 am ET Company Participants James Edgemond - Chief Financial Officer Martine Rothblatt - Chairm
United Therapeutics (UTHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? http://www.zacks.com/stock/news/394774/united-therapeutics-uthr-expected-to-beat-earnings-estimates-can-the-stock-move-higher?cid=CS-ZC-FT-394774 Apr 24, 2019 - United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biotech Stock Roundup: AMGN's Evenity Earns FDA Approval, Deal Wins & More http://www.zacks.com/stock/news/376834/biotech-stock-roundup-amgns-evenity-earns-fda-approval-deal-wins-more?cid=CS-ZC-FT-376834 Apr 10, 2019 - Key highlights of the past week are new drug approvals, collaborations and pipeline updates.
United Therapeutics Discontinues PAH Drug After Study Fails http://www.zacks.com/stock/news/373203/united-therapeutics-discontinues-pah-drug-after-study-fails?cid=CS-ZC-FT-373203 Apr 09, 2019 - United Therapeutics (UTHR) discontinues the development of esuberaprost, as the phase III study fails to meet primary endpoint.
Company News For Apr 9, 2019 http://www.zacks.com/stock/news/373099/company-news-for-apr-9-2019?cid=CS-ZC--373099 Apr 09, 2019 - Companies In The News Are: SNE, DLTR, UTHR, TWOU
United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates http://www.zacks.com/stock/news/357300/united-therapeutics-uthr-q4-earnings-sales-beat-estimates?cid=CS-ZC-FT-357300 Feb 28, 2019 - United Therapeutics (UTHR) beats estimates for both earnings and sales in the fourth quarter. Stock up.
United Therapeutics Corp (UTHR) Q4 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2019/02/27/united-therapeutics-corp-uthr-q4-2018-earnings-con.aspx?source=iedfolrf0000001 Feb 27, 2019 - UTHR earnings call for the period ending December 31, 2018.
United Therapeutics Corporation's (UTHR) CEO Martine Rothblatt on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4244836-united-therapeutics-corporations-uthr-ceo-martine-rothblatt-q4-2018-results-earnings-call?source=feed_sector_healthcare Feb 27, 2019 - United Therapeutics Corporation (NASDAQ:UTHR) Q4 2018 Results Earnings Conference Call February 27, 2019, 09:00 AM ET Company Participants James Edgemond - Chief Financial Officer Martine Rothblatt -

Pages: 1234567

Page 1>